Icure Pharmaceutical Inc (175250)

Currency in KRW
2,170
0(0.00%)
Delayed Data·
Trading near 52-week High
Trading near 52-week Low
175250 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1,9552,255
52 wk Range
1,9552,255
Key Statistics
Bid/Ask
2,160.00 / 2,180.00
Prev. Close
2,170
Open
2,050
Day's Range
1,955-2,255
52 wk Range
1,955-2,255
Volume
-
Average Volume (3m)
1.02M
1-Year Change
0%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
175250 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with low price volatility

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

Earnings

Latest Release
May 15, 2026
EPS / Forecast
-15.00 / --
Revenue / Forecast
32.19B / --
EPS Revisions
Last 90 days

175250 Income Statement

Compare 175250 to Peers and Sector

Metrics to compare
175250
Peers
Sector
Relationship
P/E Ratio
−2.5x−2.6x11.7x
PEG Ratio
0.000.020.03
Price/Book
3.1x0.8x1.5x
Price / LTM Sales
0.9x0.7x0.9x
Upside (Analyst Target)
-0.0%23.3%
Fair Value Upside
Unlock23.9%13.3%Unlock

Icure Pharmaceutical Incorporation, a biopharmaceutical company, researches, develops, and sells pharmaceutical and cosmetic products in South Korea. The company offers functional, nature-derived, derma, and customized cosmetics products. It also offers eye gel, hydro nude gel, lip gel mask, and functional patch products; and sheet, mud, foil, and melting masks. In addition, the company provides body and haircare products, including naturally derived hair and baby line, cleansing tissue, and wet wipes. Further, it offers perfumes, textile perfumes, body mists, and hair and body fragrances. Icure Pharmaceutical Incorporation was founded in 2000 and is based in Seoul, South Korea.

Employees
232

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
110.22K0.29%239.17M
Other Institutional Investors
0.00-0.00%0.00
Public Companies & Retail Investors
37.26M99.71%80.85B
Total
37.37M100.00%81.09B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Dimensional Fund Advisors LP0.29%110,215239,167
DFA Investment Dimensions Group Inc. - Emerging Markets Core Equity 2 Portfolio0.21%78,236169,772

FAQ

What Is the Icure Pharma (175250) Stock Price Today?

The Icure Pharma stock price today is 2,170 KRW.

What Stock Exchange Does Icure Pharma Trade On?

Icure Pharma is listed and trades on the KOSDAQ.

What Is the Stock Symbol for Icure Pharma?

The stock symbol for Icure Pharma is "175250."

What Is the Icure Pharma Market Cap?

As of today, Icure Pharma market cap is 81.09B KRW.

What Is Icure Pharma's Earnings Per Share (TTM)?

The Icure Pharma EPS (TTM) is -873.

From a Technical Analysis Perspective, Is 175250 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Icure Pharma Stock Split?

Icure Pharma has split 3 times.

How Many Employees Does Icure Pharma Have?

Icure Pharma has 232 employees.

What is the current trading status of Icure Pharma (175250)?

As of Aug 12, 2026, Icure Pharma (175250) is trading at a price of 2,170 KRW, with a previous close of 2,170 KRW. The stock has fluctuated within a day range of 1,955 KRW to 2,255 KRW, while its 52-week range spans from 1,955 KRW to 2,255 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.